Indian comedian dies on stage while performing stand-up act in Dubai

Agencies
July 21, 2019

Dubai, Jul 21: Indian comedian Manjunath Naidu died on stage while performing a stand-up act in Dubai.

The performer, originally from Chennai, passed away from a reported cardiac arrest on July 19 at the Signature Hotel.

"I was sitting in the front row at the show and Manjunath was the last performer of the night," PR manager Sana Topiwala told the Gulf News. "The show kicked off around 9.30 p.m. and Manjunath came on around 11.20 p.m."

According to Topiwala, 15 minutes into his act, Naidu started complaining about growing anxiety.

"He suddenly started to pant and sat down on the bench to catch his breath," Topiwala continued. "Few minutes in, he suddenly collapsed and fell to the ground in front of an audience of 80 people."

According to the eye witness, everyone assumed this was part of the act. However, after three minutes of no movement some of the comics and hotel staff members rushed on stage to administer CPR.

"We called the paramedics and followed him to Al Zahra Hospital Barsha. They attempted CPR, injected him with adrenaline but it was too late. We were informed he died of a cardiac arrest," she added.

Naidu, 36, was a well respected comedian on the UAE circuit, having performed stand-up for five years.

Comments

Mr Frank
 - 
Monday, 22 Jul 2019

A lesson to learn those were killing people by mobing ,lynching and raping.

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
coastaldigest.com web desk
July 15,2020

Mangaluru, July 15: Moulana Iqbal Mulla Nadvi, an acclaimed Islamic scholar and Qadhi (Khazi) of Bhatkal, passed away at a private hospital in Mangaluru. 

The elderly scholar was critically for past few weeks. 

He had served as the president of Jamia Islamia Bhatkal for several years.

He was known among Islamic scholars of Karnataka for his boldness, sincerity and wisdom.

Last rites are expected to be held in Bhatkal.

More details are awatied. 

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
coastaldigest.com web desk
July 1,2020

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
June 14,2020

Bengaluru, Jun 14: Karnataka Medical Education Minister K Sudhakar on Sunday said there was no question of reimposition of the lockdown amid speculation that it would be done.

"The question of lockdown is not in front of us. There is such speculation as the Prime Minister is holding a video conference with all Chief Ministers on June 16 and 17.

On June 17 our state will be taking part in it at around 3 pm," Mr Sudhakar said in response to a question.

Speaking to reporters at Kalaburagi, he said the current situation would be discussed in that meeting. Mr Sudhakar said the Prime Minister has repeatedly been holding such video conferencing exercises to take stock of the situation and plan for the future.

"There will not be a lockdown anymore according to me," he added.

There has been speculation that there would be another shutdown from this month owing to a rapid rise in the number of cases.

Listen to the latest songs, only on JioSaavn.com
Mr Sudhakar had on Friday said experts have indicated a surge in COVID-19 cases in the state in August and that the government was taking all precautionary measures in that direction.

As of June 13 evening, cumulatively 6,824 COVID-19 positive cases have been confirmed in the state, which includes 81 deaths and 3,648 discharges.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.